Knowledge hub

Featured content

Our journey to becoming IVDR compliant

157 rigorous pages, 113 articles, and 15 well-thought annexes. That is the executive summary of Devyser’s IVDR journey. Worth it? – Every day of the week! The extent of the IVDR preparation explained in a few numbers, looks straightforward. Here is how it really was.

Find out more

Filter

Publications

View all

A simple NGS method for detection of sequence variants causing alpha and beta thalassemia

One oligo-mix to detect virtually all known variants for α- and β-thalassemia.

Familial hypercholesterolemia: Genetic diagnosis and cascade testing using NGS

At present, FH is greatly underdiagnosed, and most cases are not discovered.

The role of chimerism monitoring following HSCT

Today HSCT is still the only curative treatment for patients with malignant or non-malignant hematological diseases.

Overcoming limitations in the detection of mixed chimerism

This paper highlights the importance of chimerism as a diagnostic tool for clinicians treating transplanted patients.

The latest from the Devyser blog

View all

Devyser appoints Camilla Wiberg as Chief HR Officer

On September 1, Camilla Wiberg will take up the newly established position as Chief HR Officer...

Devyser’s quality management system and fetal diagnostics product approved under the new European IVD Regulation

Devyser has today been certified under the new, more comprehensive IVD Regulation that came into...

Devyser Diagnostics AB publishes Interim Report for the period, January to June 2022

"Devyser reported another quarter of strong organic growth, which again saw record-breaking sales....